Amarin's Cost-Cutting: What It Means for Its Future Amidst Generic Competition
Amarin is cutting costs to adapt to generic competition for Vascepa. Is its strong cash position enough to stave off challenges? Here's what it could mean.

Mar 13, 2026
Mar 13, 2026
Mar 13, 2026
Mar 13, 2026
Mar 13, 2026
Mar 13, 2026
Mar 13, 2026
Mar 13, 2026
Amarin is cutting costs to adapt to generic competition for Vascepa. Is its strong cash position enough to stave off challenges? Here's what it could mean.

Life's unexpected turns can disrupt both personal and professional stability. Learn how to regain focus and productivity, especially in the dynamic crypto space.

Brent crude prices have soared amid escalating tensions that have disrupted one of the world's vital oil transit routes. As traders brace for potential $100 oil, the ripple effects are hit not just traditional markets, but digital assets as well.
